Duke Ding is a highly experienced clinical research professional currently serving as the Director, Indication Program Lead for Vaccines & Immune Therapies at AstraZeneca. Prior to this role, they held several positions at Roche, including Global Studies Manager and Senior Clinical Operations Leader, and worked as a Clinical Research Coordinator at the University Health Network. Duke is pursuing a Post-Graduate degree in Clinical Research at Humber College and an Honours Bachelor of Science in Physiology at the University of Toronto.
This person is not in the org chart
This person is not in any teams
This person is not in any offices